IRIS UniCatt

Mondi, Annalisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.563
NA - Nord America 1.553
AS - Asia 891
SA - Sud America 143
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 23
AN - Antartide 1
Totale 4.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.502
SG - Singapore 421
DE - Germania 410
PL - Polonia 315
FR - Francia 256
CN - Cina 211
SE - Svezia 168
IT - Italia 131
BR - Brasile 109
UA - Ucraina 91
VN - Vietnam 72
GB - Regno Unito 67
IN - India 54
IE - Irlanda 40
CA - Canada 31
FI - Finlandia 27
ID - Indonesia 25
TR - Turchia 19
AR - Argentina 18
JP - Giappone 15
RU - Federazione Russa 15
HK - Hong Kong 14
BD - Bangladesh 12
BE - Belgio 8
CM - Camerun 8
ES - Italia 7
IR - Iran 7
MX - Messico 7
ZA - Sudafrica 7
IQ - Iraq 6
PH - Filippine 5
AT - Austria 4
JM - Giamaica 4
KR - Corea 4
NL - Olanda 4
VE - Venezuela 4
CH - Svizzera 3
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
LT - Lituania 3
PA - Panama 3
PE - Perù 3
PK - Pakistan 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
BH - Bahrain 2
DK - Danimarca 2
LU - Lussemburgo 2
MD - Moldavia 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.174
Salva come PNG Salva come JPEG
Città #
Kraków 310
Chandler 214
Singapore 203
Ashburn 131
San Jose 99
Jacksonville 82
New York 76
Dublin 40
San Mateo 40
Ann Arbor 39
Milan 37
Los Angeles 35
Nanjing 35
Houston 34
Redmond 33
Beijing 30
Dearborn 30
The Dalles 29
Lauterbourg 28
Ho Chi Minh City 27
Nürnberg 27
Cattolica 26
Dallas 24
Jakarta 24
Wilmington 23
Lawrence 22
Redwood City 20
Boston 19
Lancaster 19
Frankfurt am Main 18
Woodbridge 17
Izmir 16
Nanchang 16
Hanoi 13
Ottawa 13
Hong Kong 12
Tokyo 12
Orem 10
Santa Clara 10
Changsha 9
Chicago 9
Hefei 9
Brussels 8
Hebei 8
Leawood 8
Munich 8
Rome 8
Seattle 8
Boardman 7
Brooklyn 7
Buffalo 7
Fairfield 7
Falls Church 7
London 7
Manchester 7
Mountain View 7
Paris 7
Shenyang 7
Fremont 6
Guangzhou 6
Montreal 6
Norwalk 6
Phoenix 6
Roubaix 6
Toronto 6
Augusta 5
Da Nang 5
Haiphong 5
Jinan 5
Johannesburg 5
Kunming 5
Little Rock 5
Moscow 5
São Paulo 5
Tianjin 5
Bari 4
Bexley 4
Biên Hòa 4
Chennai 4
Poplar 4
Pune 4
Simi Valley 4
University Park 4
Warsaw 4
Washington 4
Auburn Hills 3
Busto Arsizio 3
Cambridge 3
Caracas 3
Clearwater 3
Helsinki 3
Kish 3
Marseille 3
Miami 3
Modena 3
Oklahoma City 3
Phủ Lý 3
Rio de Janeiro 3
Shanghai 3
Amsterdam 2
Totale 2.214
Salva come PNG Salva come JPEG
Nome #
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 271
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 256
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 225
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 221
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 221
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 214
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 211
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 198
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 198
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 197
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 189
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 183
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 174
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 171
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 168
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 168
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study 154
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. 151
Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen 144
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 139
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons 137
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 120
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients 119
Totale 4.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022236 0 17 9 28 12 18 4 38 12 26 30 42
2022/2023491 75 87 32 74 44 57 7 43 62 0 5 5
2023/2024264 12 77 6 26 15 66 11 0 4 4 30 13
2024/2025463 7 16 26 24 74 15 2 31 96 33 80 59
2025/20261.018 139 10 54 137 214 45 176 62 53 80 32 16
2026/202759 25 34 0 0 0 0 0 0 0 0 0 0
Totale 4.229